These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 32376674

  • 21. Performance-enhancing drugs and the Olympics.
    Watson CJ, Stone GL, Overbeek DL, Chiba T, Burns MM.
    J Intern Med; 2022 Feb; 291(2):181-196. PubMed ID: 35007384
    [Abstract] [Full Text] [Related]

  • 22. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions.
    Alquraini H, Auchus RJ.
    Mol Cell Endocrinol; 2018 Mar 15; 464():28-33. PubMed ID: 28130115
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Competitive balance trends in elite table tennis: the Olympic Games and World Championships 1988-2016.
    Zheng J, Oh T, Kim S, Dickson G, De Bosscher V.
    J Sports Sci; 2018 Dec 15; 36(23):2675-2683. PubMed ID: 28880783
    [Abstract] [Full Text] [Related]

  • 26. Meldonium use by athletes at the Baku 2015 European Games.
    Stuart M, Schneider C, Steinbach K.
    Br J Sports Med; 2016 Jun 15; 50(11):694-8. PubMed ID: 27015859
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Participation in the International Judo Federation World Tour competitions and performance in Tokyo Olympic Games.
    Santos DFC, Kons RL, Lopes-Silva JP, Agostinho MF, Detanico D, Takito MY, Franchini E.
    Front Sports Act Living; 2023 Jun 15; 5():1216002. PubMed ID: 37440874
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.
    Di Luigi L, Pigozzi F, Sgrò P, Frati L, Di Gianfrancesco A, Cappa M.
    J Endocrinol Invest; 2020 May 15; 43(5):563-573. PubMed ID: 31734891
    [Abstract] [Full Text] [Related]

  • 40. Doping Status of DHEA Treatment for Female Athletes with Adrenal Insufficiency.
    Handelsman DJ, Matsumoto AM, Gerrard DF.
    Clin J Sport Med; 2017 Jan 15; 27(1):78-85. PubMed ID: 26844622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.